Article

Eborall, Helen C and Will, Catherine M (2011) Prevention is better than cure, but...: Preventive medication as a risk to ordinariness? Health, Risk and Society, 13 (7-8). pp. 653-668. ISSN 1363-4593

Jin, Chenggang, Ely, Adrian, Fang, Lijie and Liang, Xiaoyun (2011) Framing a global health risk from the bottom-up: user perceptions and practices around antibiotics in four villages in China. Health, Risk and Society, 13 (5). pp. 433-449. ISSN 1369-8575

Davis, Courtney and Abraham, John (2011) A comparative analysis of risk management strategies in EU and US pharmaceutical regulation. Health, Risk and Society, 13. pp. 413-31. ISSN 1369-8575

Sleeboom-Faulkner, Margaret E (2010) National risk signatures and human embryonic stem cell research in mainland China. Health, Risk and Society, 12 (5). pp. 491-511. ISSN 1369-8575

Bendelow, Gillian (2006) Pain, suffering and risk. Health, Risk and Society, 8 (1). pp. 59-70. ISSN 13698575

Lowton, Karen and Gabe, Jonathan (2006) Cystic fibrosis adults' perception and management of the risk of infection with Burkholderia cepacia complex. Health, Risk and Society, 8 (4). pp. 395-415. ISSN 1369-8575

Abraham, John and Davis, Courtney (2005) Risking public safety: experts, the medical profession and 'acceptable' drug injury. Health, Risk and Society, 7 (4). pp. 379-95. ISSN 1369-8575

Abraham, John (2002) A social science framework for the analysis of health technology regulation: the risks and benefits of innovative pharmaceuticals in a comparative context. Health, Risk and Society, 4 (3). pp. 305-24. ISSN 13698575

Abraham, John (2002) Drug safety and the safety of patients: the challenge to medicine and health from permissive expert risk assessments of triazolam (Halcion). Health, Risk and Society, 4 (1). pp. 19-29. ISSN 13698575

Abraham, John (2001) Trading risks for markets: the international harmonisation of pharmaceuticals regulation. Health, Risk and Society, 3 (1). pp. 113-28. ISSN 13698575